FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1926-1928 December 24, 1998 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Bozzette, S. A. PubMed Citation

The good news continues in the battle against AIDS. In the United States, the age-adjusted death rate among people with human immunodeficiency virus (HIV) in 1997 was less than 40 percent of what it was in 1995.^1,2 The 16,685 deaths in 1997 represent the lowest annual total in nearly a decade. That is still 16,685 deaths too many, but it is in marked contrast to the record of 43,115 deaths due to AIDS in 1995. Not only has mortality from AIDS decreased, but so has the incidence of AIDS among those who have HIV infection. Unfortunately, the incidence of newly . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Kahn, J. G., Haile, B., Kates, J., Chang, S. (2001). Health and Federal Budgetary Effects of Increasing Access to Antiretroviral Medications for HIV by Expanding Medicaid. AJPH 91: 1464-1473 [Abstract] [Full Text]  
• Steinbrook, R. (2001). Providing Antiretroviral Therapy for HIV Infection. NEJM 344: 844-846 [Full Text]  
• Horowitz, H. W., Wormser, G. P., El-Sadr, W. (1999). Atovaquone Compared with Dapsone to Prevent Pneumocystis carinii Pneumonia. NEJM 340: 1512-1513 [Full Text]